Demonstration of novel gain-of-function mutations of αIIbβ3: Association with macrothrombocytopenia and glanzmann thrombasthenia-like phenotype

Molecular Genetics and Genomic Medicine

Volumn 1, Issue 2, 2013, Pages 77-86

  Kashiwagi, Hirokazu ^a   Kunishima, Shinji ^b   Kiyomizu, Kazunobu ^a   Amano, Yoshiro ^c   Shimada, Hiroyuki ^d   Morishita, Masashi ^e   Kanakura, Yuzuru ^a   Tomiyama, Yoshiaki ^a,f  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^c NAGANO RED CROSS HOSPITAL   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOSEI GENERAL HOSPITAL   (Japan)

^f OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Congenital macrothrombocytopeniagain of function mutations; Glanzmann thrombasthenia; Integrin IIb 3; Platelets

Indexed keywords

EID: 84898057717     PISSN: None     EISSN: 23249269     Source Type: Journal    
DOI: 10.1002/mgg3.9     Document Type: Article

References (21)

1. Adzhubei, I. A., S. Schmidt, L. Peshkin, V. E. Ramensky, A. Gerasimova, P. Bork, et al. 2010. A method and server forpredicting damaging missense mutations. Nat. Methods 7:248–249
2. Bury, L., A. Malara, P. Gresele, and A. Balduini. 2012.Outside-in signalling generated by a constitutively activated integrin αIIbβ3 impairs proplatelet formation in human megakaryocytes. PLoS One 7:e34449
3. Ghevaert, C., A. Salsmann, N. A. Watkins, E. Schaffner-Reckinger, A. Rankin, S. F. Garner, et al. 2008. A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia. Blood 111:3407–3414
4. Gresele, P., E. Falcinelli, S. Giannini, P. D’Adamo, A. D’Eustacchio, T. Corazzi, et al. 2009. Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunctionin two Italian families. Haematologica 94:663–669
5. Hardisty, R., D. Pidard, A. Cox, T. Nokes, C. Legrand, C. Bouillot, et al. 1992. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder. Blood 80:696–708
6. Hodivala-Dilke, K. M., K. P. McHugh, D. A. Tsakiris, H. Rayburn, D. Crowley, M. Ullman-Culler_e, et al. 1999.Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103:229–238
7. Jayo, A., I. Conde, P. Lastres, C. Mart_ınez, J. Rivera, V. Vicente, et al. 2010. L718P mutation in the membraneproximalcytoplasmic tail of beta 3 promotes abnormal alpha IIb beta 3 clustering and lipid microdomaincoalescence, and associates with a thrombasthenia-likephenotype. Haematologica 95:1158–1166
8. Kashiwagi, H., Y. Tomiyama, S. Tadokoro, S. Honda, M. Shiraga, H. Mizutani, et al. 1999. A mutation in the extracellular cysteine-rich repeat region of the beta3 subunit activates integrins alphaIIbbeta3 and alphaVbeta3. Blood 93:2559–2568
9. Kiyoi, T., Y. Tomiyama, S. Honda, S. Tadokoro, M. Arai, H. Kashiwagi, et al. 2003. A naturally occurring Tyr143His alpha IIb mutation abolishes alpha IIb beta 3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with other mutations causing ligand-binding defects. Blood 101:3485–3491
10. Kiyomizu, K., H. Kashiwagi, T. Nakazawa, S. Tadokoro, S. Honda, Y. Kanakura, et al. 2012. Recognition of highly restricted regions in the β-propeller domain of aIIb by platelet-associated anti-αIIbβ3 autoantibodies in primary immune thrombocytopenia. Blood 120:1499–1509
11. Kunishima, S., H. Kashiwagi, M. Otsu, N. Takayama, K. Eto, M. Onodera, et al. 2011. Heterozygous ITGA2B R995Wmutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia. Blood 117:5479–5484
12. Larson, M. K., and S. P. Watson. 2006. Regulation ofproplatelet formation and platelet release by integrin alpha IIb beta3. Blood 108:1509–1514
13. Lipscomb, D. L., C. Bourne, and M. K. Boudreaux. 2000.Two genetic defects in alphaIIb are associated with type I Glanzmann’s thrombasthenia in a Great Pyrenees dog: a14-base insertion in exon 13 and a splicing defect of intron13. Vet. Pathol. 37:581–588
14. Nurden, A. T., M. Fiore, P. Nurden, and X. Pillois. 2011a.Glanzmannthrombasthenia: a review of ITGA2B and ITGB3defects with emphasis on variants, phenotypic variability, and mouse models. Blood 118:5996–6005
15. Nurden, A. T., X. Pillois, M. Fiore, R. Heilig, and P. Nurden.2011b. Glanzmann thrombasthenia-like syndromesassociated with Macrothrombocytopenias and mutations in the genes encoding the αIIbβ3 integrin. Semin. Thromb. Hemost. 37:698–706
16. Peyruchaud, O., A. T. Nurden, S. Milet, L. Macchi, A. Pannochia, P. F. Bray, et al. 1998. R to Q amino acidsubstitution in the GFFKR sequence of the cytoplasmicdomain of the integrin IIb subunit in a patient with a Glanzmann’s thrombasthenia-like syndrome. Blood 92:4178–4187
17. Ruiz, C., C. Y. Liu, Q. H. Sun, M. Sigaud-Fiks, E. Fressinaud, J. Y. Muller, et al. 2001. A point mutation in the cysteinerichdomain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype. Blood 98:2432–2441
18. Schaffner-Reckinger, E., A. Salsmann, N. Debili, J. Bellis, J. DeMey, W. Vainchenker, et al. 2009. Over expression of the partially activated alpha(IIb)beta3D723H integrin salt bridge mutant downregulates RhoA activity and induces microtubule-dependent proplatelet-like extensions in Chinese hamster ovary cells. J. Thromb. Haemost. 7:1207–1217
19. Tomiyama, Y. 2000. Glanzmann thrombasthenia: integrin alpha IIb beta 3 deficiency. Int. J. Hematol. 72:448–454.
20. Tronik-Le Roux, D., V. Roullot, C. Poujol, T. Kortulewski, P. Nurden, and G. Marguerie. 2000. Thrombasthenic micegenerated by replacement of the integrin alpha (IIb) gene:demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment. Blood 96:1399–1408
21. Ulmer, T. S. 2010. Structural basis of transmembrane domaininteractions in integrin signaling. Cell. Adh. Migr. 4:243–248.